News
BioNexus Gene Lab
BGLC · NASDAQ
$1.19+$0.00 (+0.00%)TodayMarket closed ·
Prev close $1.19
Latest news
- News
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
- News
12 Industrials Stocks Moving In Wednesday's After-Market Session
- News
12 Industrials Stocks Moving In Friday's Pre-Market Session
- News
11 Industrials Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
- News
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
- News
12 Industrials Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
- News
12 Industrials Stocks Moving In Wednesday's After-Market Session
- News
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
- News
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
- News
12 Industrials Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
- Press releaseGlobe Newswire
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
- News
12 Industrials Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
- News
12 Industrials Stocks Moving In Monday's Pre-Market Session
- News
12 Industrials Stocks Moving In Friday's Intraday Session
- News
12 Industrials Stocks Moving In Friday's Pre-Market Session
- News
12 Industrials Stocks Moving In Thursday's Pre-Market Session
- News
12 Industrials Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
US Stocks Edge Higher; Kraft Heinz Earnings Top Views
- News
12 Industrials Stocks Moving In Monday's After-Market Session
- NewsAvi Kapoor
US Stocks Mixed; UniFirst Shares Fall After Q3 Results
- News
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
US Stocks Mixed; Dow Gains Over 50 Points
- News
12 Industrials Stocks Moving In Wednesday's After-Market Session
- News
12 Industrials Stocks Moving In Monday's After-Market Session
- News
12 Industrials Stocks Moving In Thursday's Intraday Session
- News
12 Industrials Stocks Moving In Friday's Pre-Market Session
- News
12 Industrials Stocks Moving In Wednesday's After-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.